Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer Progression. | Int J Mol Sci | 2021 | 34884561 | PubTator, text mining | PubMed |
| INTS8 is a therapeutic target for intrahepatic cholangiocarcinoma via the integration of bioinformatics analysis and experimental validation. | Sci Rep | 2021 | 34880328 | PubTator, text mining | PubMed |
| Host Lung Environment Limits Aspergillus fumigatus Germination through an SskA-Dependent Signaling Response. | mSphere | 2021 | 34878292 | PubTator, text mining | PubMed |
| Lin28A/CENPE Promoting the Proliferation and Chemoresistance of Acute Myeloid Leukemia. | Front Oncol | 2021 | 34868981 | PubTator, text mining | PubMed |
| The Identification of Key Genes and Biological Pathways in Heart Failure by Integrated Bioinformatics Analysis. | Comput Math Methods Med | 2021 | 34868339 | PubTator, text mining | PubMed |
| Integrative Analysis of Epigenome and Transcriptome Data Reveals Aberrantly Methylated Promoters and Enhancers in Hepatocellular Carcinoma. | Front Oncol | 2021 | 34858848 | PubTator, text mining | PubMed |
| Establishment and Validation of a Gene Signature-Based Prognostic Model to Improve Survival Prediction in Adrenocortical Carcinoma Patients. | Int J Endocrinol | 2021 | 34858497 | PubTator, text mining | PubMed |
| Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification. | Front Pharmacol | 2021 | 34858165 | PubTator, text mining | PubMed |
| Prognostic and Clinicopathological Value of ZWINT Expression Levels in Patients with Lung Adenocarcinoma: A Systematic Review and Meta-analysis. | Clinics (Sao Paulo) | 2021 | 34852139 | PubTator, text mining | PubMed |
| SKA3 Serves as a Biomarker for Poor Prognosis in Kidney Renal Papillary Cell Carcinoma. | Int J Gen Med | 2021 | 34849004 | PubTator, text mining | PubMed |
| Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer. | Bioengineered | 2021 | 34845974 | PubTator, text mining | PubMed |
| Lipid raft-disrupting miltefosine preferentially induces the death of colorectal cancer stem-like cells. | Clin Transl Med | 2021 | 34841679 | PubTator, text mining | PubMed |
| Bioinformatics prediction and experimental verification identify MAD2L1 and CCNB2 as diagnostic biomarkers of rhabdomyosarcoma. | Cancer Cell Int | 2021 | 34838000 | PubTator, text mining | PubMed |
| The Interplay of Vitamin D Deficiency and Cellular Senescence in The Pathogenesis of Obesity-Related Co-Morbidities. | Nutrients | 2021 | 34836382 | PubTator, text mining | PubMed |
| Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer. | J Pers Med | 2021 | 34834441 | PubTator, text mining | PubMed |
| Universal Germline Testing of Unselected Cancer Patients Detects Pathogenic Variants Missed by Standard Guidelines without Increasing Healthcare Costs. | Cancers (Basel) | 2021 | 34830767 | PubTator, text mining | PubMed |
| Expression and Prognostic Role of E2F2 in Hepatocellular Carcinoma. | Int J Gen Med | 2021 | 34824545 | PubTator, text mining | PubMed |
| Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent. | Front Oncol | 2021 | 34820334 | PubTator, text mining | PubMed |
| Integrative Analysis for Elucidating Transcriptomics Landscapes of Systemic Lupus Erythematosus. | Front Genet | 2021 | 34804130 | PubTator, text mining | PubMed |
| Prognostic Value of E2F Transcription Factor Expression in Pancreatic Adenocarcinoma. | Med Sci Monit | 2021 | 34799547 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=48